Cargando…

Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients

BACKGROUND: Tissue damage caused by COVID-19 could be detected by several clinical indicators including hematological, immunological, biochemical, and inflammatory markers. This study was to detect these clinical parameters to reveal the correlation between the factors and their roles in the develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Eman T., Sajid Jabbar, Azza, Al Ali, Hadeel S., Shaheen Hamadi, Saad, Jabir, Majid S., Albukhaty, Salim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200592/
https://www.ncbi.nlm.nih.gov/pubmed/35721343
http://dx.doi.org/10.1155/2022/5735546
_version_ 1784728096892518400
author Ali, Eman T.
Sajid Jabbar, Azza
Al Ali, Hadeel S.
Shaheen Hamadi, Saad
Jabir, Majid S.
Albukhaty, Salim
author_facet Ali, Eman T.
Sajid Jabbar, Azza
Al Ali, Hadeel S.
Shaheen Hamadi, Saad
Jabir, Majid S.
Albukhaty, Salim
author_sort Ali, Eman T.
collection PubMed
description BACKGROUND: Tissue damage caused by COVID-19 could be detected by several clinical indicators including hematological, immunological, biochemical, and inflammatory markers. This study was to detect these clinical parameters to reveal the correlation between the factors and their roles in the development of COVID-19, to explore the hazard factors in severe cases. MATERIALS AND METHODS: A total of 200 participants of both sexes were included in the study, with an age range of (25–72) years, categorized into three main groups: 50 healthy individuals, 62 mild infected patients, and 88 severe infected patients with pneumonia. Different hematological and clinical parameters were included in the analysis (Basrah city, Iraq). Serum levels of interleukin-6 (IL-6), ferritin, and high-sensitivity C-reactive protein (hs-CRP) were assessed for all participants using an enzyme-linked immunosorbent assay (ELISA). The liver, renal, and cardiac functions were assessed by clinical chemistry testing. RESULTS: COVID-19 patients had leukocytosis, with an increased number of neutrophils and a decreased lymphocyte count, according to our findings. In regard to inflammatory parameters, both ESR and hs-CRP showed significant differences between the two groups, whereas IL-6 was significantly higher in the total severe group compared to the other two groups. Biochemical results revealed that each lactate dehydrogenase (LDH), ferritin, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) had significant changes in the total severe group. Among pneumonic with an O2 requirement and pneumonic without an O2 requirement, there were significant differences in immunological and inflammatory markers (p > 0.05). The neutrophils-lymphocytes ratio (NLR) was highly elevated in severe who required O2. Moreover, IL-6, lymphocytes, and neutrophils were possible risk factors for COVID-19 infection, with the strongest influence of IL-6 with a high odds ratio (OR: 24.138, 95% CI: 8.437–30.65, p < 0.01). Furthermore, there were significant correlations among the indicators. CONCLUSION: Each of IL-6, lymphocytes, and neutrophils might represent major factors in the severity of COVID-19 and IL-6 plays the main role in inducing the inflammatory and pathophysiology process that is known as the cytokine storm.
format Online
Article
Text
id pubmed-9200592
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92005922022-06-16 Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients Ali, Eman T. Sajid Jabbar, Azza Al Ali, Hadeel S. Shaheen Hamadi, Saad Jabir, Majid S. Albukhaty, Salim Int J Inflam Research Article BACKGROUND: Tissue damage caused by COVID-19 could be detected by several clinical indicators including hematological, immunological, biochemical, and inflammatory markers. This study was to detect these clinical parameters to reveal the correlation between the factors and their roles in the development of COVID-19, to explore the hazard factors in severe cases. MATERIALS AND METHODS: A total of 200 participants of both sexes were included in the study, with an age range of (25–72) years, categorized into three main groups: 50 healthy individuals, 62 mild infected patients, and 88 severe infected patients with pneumonia. Different hematological and clinical parameters were included in the analysis (Basrah city, Iraq). Serum levels of interleukin-6 (IL-6), ferritin, and high-sensitivity C-reactive protein (hs-CRP) were assessed for all participants using an enzyme-linked immunosorbent assay (ELISA). The liver, renal, and cardiac functions were assessed by clinical chemistry testing. RESULTS: COVID-19 patients had leukocytosis, with an increased number of neutrophils and a decreased lymphocyte count, according to our findings. In regard to inflammatory parameters, both ESR and hs-CRP showed significant differences between the two groups, whereas IL-6 was significantly higher in the total severe group compared to the other two groups. Biochemical results revealed that each lactate dehydrogenase (LDH), ferritin, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) had significant changes in the total severe group. Among pneumonic with an O2 requirement and pneumonic without an O2 requirement, there were significant differences in immunological and inflammatory markers (p > 0.05). The neutrophils-lymphocytes ratio (NLR) was highly elevated in severe who required O2. Moreover, IL-6, lymphocytes, and neutrophils were possible risk factors for COVID-19 infection, with the strongest influence of IL-6 with a high odds ratio (OR: 24.138, 95% CI: 8.437–30.65, p < 0.01). Furthermore, there were significant correlations among the indicators. CONCLUSION: Each of IL-6, lymphocytes, and neutrophils might represent major factors in the severity of COVID-19 and IL-6 plays the main role in inducing the inflammatory and pathophysiology process that is known as the cytokine storm. Hindawi 2022-04-21 /pmc/articles/PMC9200592/ /pubmed/35721343 http://dx.doi.org/10.1155/2022/5735546 Text en Copyright © 2022 Eman T. Ali et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ali, Eman T.
Sajid Jabbar, Azza
Al Ali, Hadeel S.
Shaheen Hamadi, Saad
Jabir, Majid S.
Albukhaty, Salim
Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients
title Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients
title_full Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients
title_fullStr Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients
title_full_unstemmed Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients
title_short Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients
title_sort extensive study on hematological, immunological, inflammatory markers, and biochemical profile to identify the risk factors in covid-19 patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200592/
https://www.ncbi.nlm.nih.gov/pubmed/35721343
http://dx.doi.org/10.1155/2022/5735546
work_keys_str_mv AT aliemant extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients
AT sajidjabbarazza extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients
AT alalihadeels extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients
AT shaheenhamadisaad extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients
AT jabirmajids extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients
AT albukhatysalim extensivestudyonhematologicalimmunologicalinflammatorymarkersandbiochemicalprofiletoidentifytheriskfactorsincovid19patients